Immunotherapy News and Research

Latest Immunotherapy News and Research

UCSF researchers discover a new way to control immune system's 'natural killer' cells

UCSF researchers discover a new way to control immune system's 'natural killer' cells

Proteogenomics can help determine effective treatment for head and neck squamous cell carcinoma

Proteogenomics can help determine effective treatment for head and neck squamous cell carcinoma

MD Anderson and Xencor to develop novel antibody therapeutics to treat cancer patients

MD Anderson and Xencor to develop novel antibody therapeutics to treat cancer patients

Scientists develop a new method to study the molecular characteristics of T cells

Scientists develop a new method to study the molecular characteristics of T cells

Gut microbe may play a role in the development of breast cancers

Gut microbe may play a role in the development of breast cancers

Researchers reveal distinct molecular signature in tumor tissues of Black breast cancer patients

Researchers reveal distinct molecular signature in tumor tissues of Black breast cancer patients

NCCN publishes new informational resources on health and wellness for cancer survivors

NCCN publishes new informational resources on health and wellness for cancer survivors

Researchers discover new metabolic vulnerability in a highly aggressive form of lung cancer

Researchers discover new metabolic vulnerability in a highly aggressive form of lung cancer

Increased pollen counts may trigger symptom flares in patients with urologic chronic pelvic pain syndrome

Increased pollen counts may trigger symptom flares in patients with urologic chronic pelvic pain syndrome

Researchers discover protein crucial to T cell metabolism and anti-tumor immune response

Researchers discover protein crucial to T cell metabolism and anti-tumor immune response

Study uncovers why cancer patients with liver metastases have poor outcomes

Study uncovers why cancer patients with liver metastases have poor outcomes

New cell therapy can boost immunotherapy against breast cancer

New cell therapy can boost immunotherapy against breast cancer

Researchers discover how chromosomal instability allows cancer cells to avoid immune defenses

Researchers discover how chromosomal instability allows cancer cells to avoid immune defenses

Scientists identify distinct sub-types of angiosarcomas to allow for targeted treatment

Scientists identify distinct sub-types of angiosarcomas to allow for targeted treatment

Study reveals how the immune system detects signs of disease, activates a protective response

Study reveals how the immune system detects signs of disease, activates a protective response

Researchers demonstrate potential preventive treatment for Crohn's disease

Researchers demonstrate potential preventive treatment for Crohn's disease

Arthritis drug may be effective in treating immunotherapy-related heart complication

Arthritis drug may be effective in treating immunotherapy-related heart complication

Study finds how macrophages may contribute to a therapeutic weak spot in breast cancer

Study finds how macrophages may contribute to a therapeutic weak spot in breast cancer

FDA approves pembrolizumab as first-line treatment for colorectal cancer

FDA approves pembrolizumab as first-line treatment for colorectal cancer

Regulating fas protein may be a route to prevent cancer relapse after immunotherapy

Regulating fas protein may be a route to prevent cancer relapse after immunotherapy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.